Kissei Pharmaceutical Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Kissei Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥4,967. The average 1-year stock price forecast is 25.90% higher than the current stock price, while the lowest is ¥4,100 (+3.93%) and the highest is ¥5,500 (+39.42%).

Price Target: ¥4,967 (+25.90%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	¥4,100	¥4,967	¥4,950	¥5,500
Change	+3.93%	+25.90%	+25.48%	+39.42%

Analyst Ratings

The average analyst rating for Kissei Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	1	2	2	2
Buy	2	2	2	2	2	1
Hold	2	2	2	2	2	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Nomura No rating	Nomura	Hold Downgrades ¥5,600 → ¥4,100	Hold	Downgrades	¥5,600 → ¥4,100	+3.93%	Jun 5, 2026
Unknown Analyst SBI Securities No rating	SBI Securities	Hold Maintains ¥3,760	Hold	Maintains	¥3,760	-4.69%	Jun 4, 2026
Miyabi Yamakita Jefferies	Jefferies	Buy Maintains ¥5,400 → ¥4,800	Buy	Maintains	¥5,400 → ¥4,800	+21.67%	May 25, 2026
Unknown Analyst Daiwa No rating	Daiwa	Buy Maintains ¥5,500	Buy	Maintains	¥5,500	+39.42%	Jan 29, 2026
Mark Yokoyama UBS No rating	UBS	Hold Initiates ¥4,900	Hold	Initiates	¥4,900	+24.21%	Dec 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

93.73B

from 97.41B

-3.77%

from 97.41B

Revenue Next Year

100.06B

from 93.73B

6.75%

from 93.73B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	65.38B	67.49B	75.58B	88.33B	97.41B	93.73B
Revenue Growth	-5.31%	3.23%	11.98%	16.87%	10.28%	-3.77%
Gross Profit	31.24B	32.38B	37.34B	44.07B	45.82B	44.55B
Gross Margin	47.78%	47.97%	49.41%	49.89%	47.04%	47.53%
Operating Income	-1.40B	-1.14B	4.02B	5.77B	-2.93B	5.49B
Net Income	12.92B	10.53B	11.16B	11.96B	13.78B	9.54B
Dividend / Share	56.00	80.00	82.00	100.00	120.00	154.40
Dividend Growth	-	42.86%	2.50%	21.95%	20.00%	28.67%
Free Cash Flow	3.84B	-7.65B	200.38M	2.45B	82.75M	10.01B
No. Analysts	-	-	-	-	-	6

Financial currency is JPY.

Revenue Forecast

Revenue	2027	2028	2029
High	98.4B
Avg	93.7B
Low	82.8B

Revenue Growth

Revenue Growth	2027	2028	2029
High	1.0%
Avg	-3.8%
Low	-15.0%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2028	2029
High	-
Avg	-
Low	-